Oculus Innovative Sciences Reports Financial Results for the Fourth Quarter of Fiscal Year 2015 Jun 11, 2015
Oculus Innovative Sciences Receives FDA Clearance for Novel Atopic Dermatitis Dermatology Product Jun 8, 2015
Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2015 Financial Results and Conference Call May 28, 2015
Oculus Innovative Sciences Announces Launch of MicrocynAH(R) Farm and Ranch Animal Healthcare Products Apr 16, 2015
Oculus Innovative Sciences Announces Sale of 350,000 Shares of Ruthigen Stock for $962,500 in Non-Dilutive Funding Mar 16, 2015
Oculus Innovative Sciences Announces New Animal Healthcare Division and Launch of MicrocynAH(R) Advanced All-Animal Healthcare Products Feb 26, 2015
Oculus Innovative Sciences Reports Financial Results for the Third Quarter of Fiscal Year 2015 Feb 12, 2015
Oculus Innovative Sciences Announces Fiscal Third Quarter 2015 Financial Results and Conference Call Jan 29, 2015
Oculus Innovative Sciences Announces Closing of $6.3 Million Underwritten Public Offering Jan 26, 2015
Oculus Innovative Sciences Announces Pricing of Upsized $6.3 Million Underwritten Public Offering Jan 21, 2015
